AMMONIA - PLASMA

Ammonia - Plasma is a specialized blood test used to measure the concentration of ammonia present in plasma. Ammonia is a potentially toxic waste product formed mainly during the breakdown of proteins and amino acids. It is normally transported to the liver, converted into urea through the urea cycle, and eliminated from the body through the kidneys.

When the liver cannot process ammonia effectively, when blood bypasses the liver, or when an inherited metabolic disorder affects the urea cycle, ammonia may accumulate in the bloodstream. Excess ammonia can affect the brain and nervous system, causing a condition known as hyperammonemia. This test supports the evaluation of advanced liver disease, hepatic encephalopathy, unexplained neurological symptoms, and inherited metabolic disorders.

Benefits of the Test

• Measures ammonia concentration in plasma.
• Supports evaluation of suspected hyperammonemia.
• Assists in assessing hepatic encephalopathy and hepatic coma.
• Helps evaluate patients with advanced liver disease or liver failure.
• Supports investigation of inherited urea-cycle disorders.
• Helps monitor treatment for elevated ammonia levels.
• Assists in evaluating unexplained changes in consciousness.
• Provides rapid laboratory-based assessment when clinically urgent.

Why Doctors Recommend This Test

Doctors may recommend this test for patients with severe liver disease who develop confusion, unusual behavior, excessive sleepiness, disorientation, tremors, slurred speech, seizures, or reduced consciousness. It may also be advised for newborns, infants, or children with unexplained vomiting, poor feeding, lethargy, rapid breathing, seizures, developmental problems, or suspected inherited urea-cycle disorders.

Preparation Before Test

• Fasting may be advised depending on the patient's condition and laboratory protocol.
• A plasma blood sample is required for testing.
• Inform the doctor about medicines, supplements, liver disease, kidney disease, and metabolic disorders.
• Avoid strenuous exercise immediately before collection unless otherwise instructed.
• Do not stop prescribed medicines without medical advice.
• The blood sample should be placed on ice immediately after collection.
• Plasma must be separated from blood cells promptly using the recommended procedure.
• The sample should remain cold and be analysed quickly or frozen within the required time.
• Strict sample-handling instructions must be followed to prevent a falsely elevated result.

Normal Reporting Time

Most Ammonia - Plasma reports at Focus Diagnostics are initiated promptly after sample receipt because ammonia requires rapid processing and controlled sample handling. Analysis and preliminary reporting may generally be completed within several hours when the sample is collected and transported correctly. Final validation and reporting depend on laboratory workflow, clinical urgency, sample suitability, and quality-assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Patients with cirrhosis or advanced liver disease.
• Individuals with suspected hepatic encephalopathy.
• Patients with acute or chronic liver failure.
• People with unexplained confusion, lethargy, or altered consciousness.
• Newborns or children with suspected urea-cycle disorders.
• Patients experiencing unexplained seizures or neurological deterioration.
• Individuals undergoing treatment for hyperammonemia.
• Patients with suspected metabolic disease affecting ammonia removal.

Detailed Information

Ammonia is continuously produced in the body during protein and amino acid metabolism. Intestinal bacteria also generate ammonia during the digestion of nitrogen-containing substances. Most ammonia travels through the bloodstream to the liver, where it is converted into urea through a series of biochemical reactions known as the urea cycle.

Urea is considerably less toxic than ammonia and is removed from the bloodstream by the kidneys. If liver function becomes severely impaired, the liver may not convert ammonia efficiently. Abnormal blood flow that bypasses the liver, known as portosystemic shunting, can also allow ammonia to enter the general circulation without adequate detoxification.

Elevated blood ammonia is known as hyperammonemia. Because ammonia is toxic to the central nervous system, significantly increased levels may contribute to brain swelling, confusion, behavioral changes, impaired coordination, seizures, coma, and other neurological complications.

Hepatic encephalopathy is a neurological complication that may occur in patients with advanced liver disease. Symptoms can range from mild changes in concentration, sleep, or personality to severe confusion, drowsiness, and coma. Ammonia testing may support the evaluation, but the ammonia concentration does not always correlate closely with the presence or clinical severity of hepatic encephalopathy.

An elevated ammonia result should therefore not be used alone to diagnose or grade hepatic encephalopathy. Doctors interpret the result together with symptoms, physical examination, liver-function tests, kidney function, infection status, medicines, gastrointestinal bleeding, electrolyte abnormalities, imaging findings, and other investigations.

Hyperammonemia may also occur in newborns and children with inherited urea-cycle disorders. These conditions result from a deficiency of an enzyme or transport protein required to convert ammonia into urea. Symptoms may include poor feeding, vomiting, irritability, lethargy, rapid breathing, abnormal muscle tone, seizures, developmental delay, or coma.

Other metabolic disorders, including certain organic acidemias and fatty-acid oxidation disorders, may also produce elevated ammonia. Further investigations may include plasma amino acids, urine organic acids, blood acylcarnitines, glucose, lactate, blood gases, liver-function tests, and molecular genetic testing.

Accurate ammonia measurement depends heavily on correct collection and handling. Ammonia levels can increase after blood collection if the sample remains in contact with blood cells, becomes warm, or is not processed promptly. The sample should be placed on ice immediately, centrifuged under controlled conditions, and the plasma separated quickly.

False elevations may also occur because of difficult collection, prolonged processing, hemolysis, inappropriate storage, or delayed transport. If a result is unexpectedly high and does not match the patient's condition, repeat collection under strict pre-analytical conditions may be necessary.

Patients with confirmed hyperammonemia require medical evaluation to identify and treat the underlying cause. Treatment depends on severity and may involve addressing liver-related triggers, reducing ammonia production or absorption, correcting metabolic disturbances, providing specialized nutrition, using ammonia-lowering medicines, or initiating emergency metabolic treatment.

Severe confusion, repeated vomiting, seizures, marked drowsiness, breathing changes, or reduced consciousness may indicate a medical emergency. Laboratory testing should not delay immediate clinical assessment and treatment.

At Focus Diagnostics, Ammonia - Plasma testing is performed using validated biochemical methodologies, rapid sample-processing procedures, temperature-controlled handling, and stringent quality-assurance standards to provide accurate, reliable, and clinically meaningful results.